Skip to content

Comparison of perioperative Outcomes following four-port, three-port and single incision laparoscopic cholecystectomy

Comparison of perioperative Outcomes following four port, three port and single incision laparoscopic cholecystectomy in patients of shariati hospital in 2011

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201105152982N4
Enrollment
90
Registered
2011-12-23
Start date
2011-06-01
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cholecystitis. ??? ??????? ???? ???? (??? ?? ????)

Interventions

Intervention 1: Control group(4 port): In this group, 4 laparoscopic port are used for cholesystemy. 10-mm port in the umblicus, 5 mm port in epigastric area (sub-xiphoid), 5 mm port in midclavicular
Treatment - Surgery
Control group(4 port): In this group, 4 laparoscopic port are used for cholesystemy. 10-mm port in the umblicus, 5 mm port in epigastric area (sub-xiphoid), 5 mm port in midclavicular line about 2 cm
Intervention group 1 (3 port cholecystectomy): In this group one 10-mm port in inserted from the umblical area and two 5 mm ports are inserted in epigastric area (sub-xiphoid) and right midclavicular
Intervention group 2 (Single incision laparoscopic cholecystectomy): In this group a 2 cm vertical incision is made in the umblicus and all three ports (one 10-mm and two 5-mm ports) are inserted from

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Indication for laparoscopic cholecystectomy, Informed consent for participating in the study Exclusion Criteria: Severe inflammation of gallbladder, Bile duct stone needing bile exploration, Drug addiction, planned surgery not progressed

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Postoperative narcotic usage. Timepoint: Continousely recorded and measured at the time of discharge. Method of measurement: Patient controlled analgesia device.

Secondary

MeasureTime frame
Postoperative nausea and vomiting. Timepoint: 12 hours intervals till discharge. Method of measurement: History taking.;Wound infection. Timepoint: At the time of discharge and 7 days later. Method of measurement: Physical examination.;Intraoperative adverse events. Timepoint: At the end of surgery. Method of measurement: Questionnaire for the surgeon.;Surgeon opinion about surgery difficulty. Timepoint: At the end of surgery. Method of measurement: Questionn to the surgeon with likert scale.;Post operathve Hospital stay. Timepoint: At the time of discharge. Method of measurement: based on medical reocords.;Patient's satisfaction about cosmetic outcome. Timepoint: 3 months after surgery. Method of measurement: Question with likert scale.;Other systematic postoperative complication. Timepoint: At the time of discharge and 30 days later. Method of measurement: History taking and clinical records.;Postoperative pain. Timepoint: 6 hours intervals for 24 hours. Method of measurement: Visual analogue scale.;Surgery duration. Timepoint: At the end of surgery. Method of measurement: Stopwatch.;Bile leakage or bile duct trauma. Timepoint: At the time of discharge and 30 days later. Method of measurement: Clinical records.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZhamak Khorgami

Tehran University of Medical Sciences - Shariati Hospital

khorgami@gmail.com+98 21 8490 2450

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026